HomeInsightsStock Comparison

Syncom Formulations India Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Syncom Formulations India Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Syncom Formulations (India) Ltd is ₹ 18.3 as of 22 Jul 12:06.
  • The P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 60.9 on March 2022 to 57.3 on March 2025 . This represents a CAGR of -1.01% over 6 years.
  • The Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 47318 crore on March 2022 to ₹ 109468 crore on March 2025 . This represents a CAGR of 15.00% over 6 years.
  • The revenue of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 155.83 crore as compare to the Dec '24 revenue of ₹ 131.57 crore. This represent the growth of 18.44% The revenue of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 2941 crore as compare to the Dec '24 revenue of ₹ 2842 crore. This represent the growth of 3.48%.
  • The ebitda of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 24.7 crore as compare to the Dec '24 ebitda of ₹ 18.77 crore. This represent the growth of 31.59% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '25 is ₹ 922 crore as compare to the Dec '24 ebitda of ₹ 947 crore. This represent the decline of -2.64%.
  • The net profit of Syncom Formulations (India) Ltd changed from ₹ 4.4 crore to ₹ 17.69 crore over 8 quarters. This represents a CAGR of 100.51% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 498 crore over 8 quarters. This represents a CAGR of 14.78% .
  • The Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 10.76 % on March 2025 . This represents a CAGR of -24.42% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

14 May 2025 14:06

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 2024 14:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 17:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 10:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 2024 13:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 2024 11:37

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals to hold board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28...

Read more

22 Jul 2025 10:21

News

Torrent Pharmaceuticals Ltd gains for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

18 Jul 2025 13:00

News

Torrent Pharmaceuticals AGM scheduled

Torrent Pharmaceuticals announced that the 52th Annual General Meeting(AGM) of the company...

Read more

05 Jul 2025 17:16

News

Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma

Shares of JB Chemicals & Pharmceuticals declined 6.63% to Rs 1,680.05 on the BSE. The acqu...

Read more

30 Jun 2025 16:02

News

Torrent Pharmaceuticals Ltd spurts 0.03%, gains for five straight sessions

Torrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting ...

Read more

09 Jun 2025 13:00

News

Board of Torrent Pharmaceuticals recommends final dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

20 May 2025 20:32

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Syncom Formulations (India) Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Syncom Formulations (India) Ltd is 1,727 Cr while Market cap of Torrent Pharmaceuticals Ltd is 119,271 Cr

What are the key factors driving the stock performance of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd?

As of July 22, 2025, the Syncom Formulations (India) Ltd stock price is INR ₹18.38. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3524.25.

How do dividend payouts of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Syncom Formulations (India) Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions